Moreover, an HA‐labeled PLGA nanoparticle encapsulating both paclitaxel and focal adhesion kinase siRNA was reported to bind to CD44‐positive epithelial ovarian cancer cells to overcome chemoresistance.287. This evidence concerns the gene CD44 and ovarian carcinoma.